Jan 20, 2021Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAIDEMERYVILLE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company...
Jan 12, 2021Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’ SoftBank Vision Fund 2, Alaska Permanent Fund Corporation, Altitude Life Science Ventures, Qatar Investment Authority, and Other New...
Jan 7, 2021Top Life Sciences Startups to Watch in 2021BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that...